SCHEMBL681689

SCHEMBL681689

C=C(C(C)C)[C@H](CN[C@@H]1CCN(C(C)=O)C1)c1ccc(Cl)cc1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 2/20 0.41
CCR1 P32246 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
MITF O75030 1/20 0.40
AKT2 P31751 4/20 0.39
AKT3 Q9Y243 4/20 0.39
AKT1 P31749 3/20 0.39
LTA4H P09960 2/20 0.37
EPHX2 P34913 2/20 0.37
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
KDM5A P29375 1/20 0.37
TRPV1 Q8NER1 1/20 0.36
C3AR1 Q16581 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL681305 1.00 OPRL1 (0.41) OPRL1CCR1MEN1KMT2AMITF
SCHEMBL681145 0.93 OPRL1 (0.43) OPRL1CCR1MEN1KMT2AMITF
SCHEMBL680942 0.90 CCR1 (0.43) OPRL1CCR1MEN1KMT2AMITF
SCHEMBL679642 0.90 CCR1 (0.43) OPRL1CCR1MEN1KMT2AMITF
SCHEMBL684155 0.89 OPRL1 (0.43) OPRL1CCR1MEN1KMT2AMITF
SCHEMBL684409 0.89 OPRL1 (0.43) OPRL1CCR1MEN1KMT2AMITF
SCHEMBL2738624 0.87 OPRL1 (0.42) OPRL1CCR1MEN1KMT2AMITF
SCHEMBL681206 0.83 OPRL1 (0.44) OPRL1CCR1MEN1KMT2AMITF
SCHEMBL681566 0.82 MEN1 (0.40) MEN1KMT2AMITFAKT2AKT3
SCHEMBL684412 0.82 OPRL1 (0.46) OPRL1MEN1KMT2AMITFAKT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9359340-B2 Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitors ARRAY BIOPHARMA INC. (US) 2016-06-07 US disclosed
US-8063050-B2 Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors ARRAY BIOPHARMA INC. (US) 2011-11-22 US disclosed